Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides

Details for Australian Patent Application No. 2007200732 (hide)

Owner Eli Lilly and Company

Inventors Dodd, Steven Witt; Trautmann, Michael Ernst; Mace, Kenneth Francis

Agent Wrays

Pub. Number AU-A-2007200732

Parent 2002239384

Filing date 19 February 2007

Wipo publication date 8 March 2007

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

8 March 2007 Application Open to Public Inspection

  Published as AU-A-2007200732

8 March 2007 Complete Application Filed

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200733-Monitoring Z-Values for Clinical Data Interpretation

2007200731-Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same